# StepStone Group Inc.: financial statements, quarterly

STEP · Nasdaq · CIK 1796022 · [Financials](/sectors/financials.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/step.md) · [Financials](/companies/step/financials.md) · [Filings](/companies/step/filings.md) · [Insiders](/companies/step/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/step/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [191](/filings/0001796022-24-000088.md) | [(14.6)](/filings/0001796022-25-000008.md) | [357 d](/filings/0001628280-26-038446.md) | [186](/filings/0001796022-25-000060.md) | [272](/filings/0001628280-25-050217.md) | [339](/filings/0001628280-26-005769.md) | [378 d](/filings/0001628280-26-038446.md) | [364](/filings/0001628280-26-054818.md) | [454](/filings/0001628280-25-050217.md) | [587](/filings/0001628280-26-005769.md) | [589 d](/filings/0001628280-26-038446.md) | [379](/filings/0001628280-26-054818.md) |
| Interest expense | $m | [2.1](/filings/0001796022-23-000080.md) | [2.6](/filings/0001796022-24-000008.md) | [2.6 d](/filings/0001796022-24-000041.md) | [3.0](/filings/0001796022-25-000060.md) | [3.5](/filings/0001628280-25-050217.md) | [3.0](/filings/0001628280-26-005769.md) | [3.2 d](/filings/0001628280-26-038446.md) | [4.5](/filings/0001628280-26-054818.md) | [4.4](/filings/0001628280-25-050217.md) | [5.1](/filings/0001628280-26-005769.md) | [4.4 d](/filings/0001628280-26-038446.md) | [4.3](/filings/0001628280-26-054818.md) |
| Income tax | $m | [7.7](/filings/0001796022-24-000088.md) | [(0.7)](/filings/0001796022-25-000008.md) | [12.0 d](/filings/0001628280-26-038446.md) | [6.8](/filings/0001796022-25-000060.md) | [4.8](/filings/0001628280-25-050217.md) | [(57.6)](/filings/0001628280-26-005769.md) | [(3.2) d](/filings/0001628280-26-038446.md) | [(8.3)](/filings/0001628280-26-054818.md) | [(100)](/filings/0001628280-25-050217.md) | [(32.2)](/filings/0001628280-26-005769.md) | [(7.0) d](/filings/0001628280-26-038446.md) | [(29.9)](/filings/0001628280-26-054818.md) |
| Net income | $m | [26.2](/filings/0001796022-24-000088.md) | [(20.2)](/filings/0001796022-25-000008.md) | [30.8 d](/filings/0001628280-26-038446.md) | [13.3](/filings/0001796022-25-000060.md) | [17.6](/filings/0001628280-25-050217.md) | [(192)](/filings/0001628280-26-005769.md) | [(18.5) d](/filings/0001628280-26-038446.md) | [(38.4)](/filings/0001628280-26-054818.md) | [(366)](/filings/0001628280-25-050217.md) | [(123)](/filings/0001628280-26-005769.md) | [(7.8) d](/filings/0001628280-26-038446.md) | [(116)](/filings/0001628280-26-054818.md) |
| Diluted EPS | $ per share | [0.42](/filings/0001796022-24-000088.md) | [(0.32)](/filings/0001796022-25-000008.md) | not reported | [0.20](/filings/0001796022-25-000060.md) | [0.26](/filings/0001628280-25-050217.md) | [(2.61)](/filings/0001628280-26-005769.md) | not reported | [(0.49)](/filings/0001628280-26-054818.md) | [(4.66)](/filings/0001628280-25-050217.md) | [(1.55)](/filings/0001628280-26-005769.md) | not reported | [(1.41)](/filings/0001628280-26-054818.md) |
| Basic EPS | $ per share | [0.42](/filings/0001796022-24-000088.md) | [(0.32)](/filings/0001796022-25-000008.md) | not reported | [0.20](/filings/0001796022-25-000060.md) | [0.26](/filings/0001628280-25-050217.md) | [(2.61)](/filings/0001628280-26-005769.md) | not reported | [(0.49)](/filings/0001628280-26-054818.md) | [(4.66)](/filings/0001628280-25-050217.md) | [(1.55)](/filings/0001628280-26-005769.md) | not reported | [(1.41)](/filings/0001628280-26-054818.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [3,608](/filings/0001796022-23-000080.md) | [3,468](/filings/0001796022-24-000008.md) | [3,789](/filings/0001796022-25-000041.md) | [3,834](/filings/0001796022-24-000063.md) | [4,040](/filings/0001796022-24-000088.md) | [4,350](/filings/0001796022-25-000008.md) | [4,587](/filings/0001628280-26-038446.md) | [4,782](/filings/0001796022-25-000060.md) | [5,332](/filings/0001628280-25-050217.md) | [5,241](/filings/0001628280-26-005769.md) | [6,763](/filings/0001628280-26-054818.md) | [7,768](/filings/0001628280-26-054818.md) |
| Total liabilities | $m | [1,911](/filings/0001796022-23-000080.md) | [1,802](/filings/0001796022-24-000008.md) | [1,916](/filings/0001796022-25-000041.md) | [1,895](/filings/0001796022-24-000063.md) | [2,040](/filings/0001796022-24-000088.md) | [2,606](/filings/0001796022-25-000008.md) | [2,812](/filings/0001628280-26-038446.md) | [3,085](/filings/0001796022-25-000060.md) | [4,106](/filings/0001628280-25-050217.md) | [4,722](/filings/0001628280-26-005769.md) | [5,877](/filings/0001628280-26-054818.md) | [6,528](/filings/0001628280-26-054818.md) |
| Long-term debt | $m | [124](/filings/0001796022-23-000080.md) | [124](/filings/0001796022-24-000008.md) | [149](/filings/0001796022-25-000041.md) | [172](/filings/0001796022-24-000063.md) | [172](/filings/0001796022-24-000088.md) | [169](/filings/0001796022-25-000008.md) | [269](/filings/0001628280-26-005769.md) | [270](/filings/0001796022-25-000060.md) | [270](/filings/0001628280-25-050217.md) | [270](/filings/0001628280-26-005769.md) | not reported | not reported |
| Shareholders' equity | $m | [795](/filings/0001796022-23-000080.md) | [762](/filings/0001796022-24-000008.md) | [324](/filings/0001796022-25-000041.md) | [367](/filings/0001796022-24-000063.md) | [397](/filings/0001796022-24-000088.md) | [210](/filings/0001796022-25-000008.md) | [179](/filings/0001628280-26-038446.md) | [154](/filings/0001796022-25-000060.md) | [(233)](/filings/0001628280-25-050217.md) | [(379)](/filings/0001628280-26-005769.md) | [(414)](/filings/0001628280-26-054818.md) | [(539)](/filings/0001628280-26-054818.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [71.1 d](/filings/0001796022-24-000088.md) | [25.2 d](/filings/0001796022-25-000008.md) | [7.6 d](/filings/0001628280-26-038446.md) | [50.2](/filings/0001796022-25-000060.md) | [53.7 d](/filings/0001628280-25-050217.md) | [27.6 d](/filings/0001628280-26-005769.md) | [(66.5) d](/filings/0001628280-26-038446.md) | [46.3](/filings/0001628280-26-054818.md) | [16.2 d](/filings/0001628280-25-050217.md) | [27.2 d](/filings/0001628280-26-005769.md) | [(23.2) d](/filings/0001628280-26-038446.md) | [(458)](/filings/0001628280-26-054818.md) |
| Capital expenditure | $m | [6.8 d](/filings/0001796022-24-000088.md) | [4.1 d](/filings/0001796022-25-000008.md) | [0.9 d](/filings/0001628280-26-038446.md) | [0.6](/filings/0001796022-25-000060.md) | [1.3 d](/filings/0001628280-25-050217.md) | [0.6 d](/filings/0001628280-26-005769.md) | [2.7 d](/filings/0001628280-26-038446.md) | [1.1](/filings/0001628280-26-054818.md) | [0.3 d](/filings/0001628280-25-050217.md) | [0.4 d](/filings/0001628280-26-005769.md) | [0.8 d](/filings/0001628280-26-038446.md) | [0.5](/filings/0001628280-26-054818.md) |
| Dividends paid | $m | [13.3 d](/filings/0001796022-24-000088.md) | [13.5 d](/filings/0001796022-25-000008.md) | [13.5 d](/filings/0001628280-26-038446.md) | [23.8](/filings/0001796022-25-000060.md) | [16.3 d](/filings/0001628280-25-050217.md) | [17.5 d](/filings/0001628280-26-005769.md) | [18.3 d](/filings/0001628280-26-038446.md) | [50.3](/filings/0001628280-26-054818.md) | [22.0 d](/filings/0001628280-25-050217.md) | [22.2 d](/filings/0001628280-26-005769.md) | [23.3 d](/filings/0001628280-26-038446.md) | [68.6](/filings/0001628280-26-054818.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001628280-26-054818.md) | not reported | not reported | not reported | [19.2](/filings/0001628280-26-054818.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [61.4](/filings/0001796022-23-000080.md) | [62.2](/filings/0001796022-24-000008.md) | [65.7](/filings/0001796022-24-000063.md) | [66.2](/filings/0001796022-24-000088.md) | [64.1](/filings/0001796022-25-000008.md) | [68.6](/filings/0001796022-25-000060.md) | [69.7](/filings/0001628280-25-050217.md) | [73.7](/filings/0001628280-26-005769.md) | [77.8](/filings/0001628280-26-054818.md) | [78.6](/filings/0001628280-25-050217.md) | [79.5](/filings/0001628280-26-005769.md) | [82.0](/filings/0001628280-26-054818.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.